- Home
- ADMA vs HIMS Comparison
ADMA vs HIMS Comparison
Compare ADMA & HIMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADMA
- HIMS
- Stock Information
- Founded
- ADMA 2004
- HIMS 2017
- Country
- ADMA United States
- HIMS United States
- Employees
- ADMA N/A
- HIMS N/A
- Industry
- ADMA Biotechnology: Biological Products (No Diagnostic Substances)
- HIMS Medical/Nursing Services
- Sector
- ADMA Health Care
- HIMS Health Care
- Exchange
- ADMA Nasdaq
- HIMS Nasdaq
- Market Cap
- ADMA 5.8B
- HIMS 6.0B
- IPO Year
- ADMA N/A
- HIMS N/A
- Fundamental
- Price
- ADMA $19.98
- HIMS $51.98
- Analyst Decision
- ADMA Strong Buy
- HIMS Hold
- Analyst Count
- ADMA 4
- HIMS 12
- Target Price
- ADMA $24.25
- HIMS $37.67
- AVG Volume (30 Days)
- ADMA 4.5M
- HIMS 46.8M
- Earning Date
- ADMA 05-07-2025
- HIMS 05-05-2025
- Dividend Yield
- ADMA N/A
- HIMS N/A
- EPS Growth
- ADMA N/A
- HIMS N/A
- EPS
- ADMA 0.84
- HIMS 0.68
- Revenue
- ADMA $459,381,000.00
- HIMS $1,784,353,000.00
- Revenue This Year
- ADMA $18.45
- HIMS $60.78
- Revenue Next Year
- ADMA $26.96
- HIMS $18.96
- P/E Ratio
- ADMA $23.92
- HIMS $76.25
- Revenue Growth
- ADMA 62.23
- HIMS 85.99
- 52 Week Low
- ADMA $6.84
- HIMS $12.07
- 52 Week High
- ADMA $25.67
- HIMS $72.98
- Technical
- Relative Strength Index (RSI)
- ADMA 43.06
- HIMS 75.47
- Support Level
- ADMA $18.75
- HIMS $38.21
- Resistance Level
- ADMA $23.98
- HIMS $54.75
- Average True Range (ATR)
- ADMA 1.38
- HIMS 3.97
- MACD
- ADMA -0.34
- HIMS 2.77
- Stochastic Oscillator
- ADMA 17.77
- HIMS 90.65
About ADMA ADMA Biologics Inc
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.
About HIMS Hims & Hers Health Inc.
Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, haircare and more.